REGENERON PHARMACEUTICALS, INC. Quarterly Other Assets, Noncurrent in USD from Q2 2010 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of noncurrent assets classified as other.
Summary
Regeneron Pharmaceuticals, Inc. quarterly Other Assets, Noncurrent history and growth rate from Q2 2010 to Q3 2024.
  • Regeneron Pharmaceuticals, Inc. Other Assets, Noncurrent for the quarter ending September 30, 2024 was $1.04B, a 154% increase year-over-year.
Other Assets, Noncurrent, Quarterly (USD)
Other Assets, Noncurrent, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q3 2024 $1.04B +$633M +154% Sep 30, 2024 10-Q 2024-10-31
Q2 2024 $994M +$601M +153% Jun 30, 2024 10-Q 2024-08-01
Q1 2024 $470M +$121M +34.5% Mar 31, 2024 10-Q 2024-05-02
Q4 2023 $444M +$108M +32% Dec 31, 2023 10-Q 2024-10-31
Q3 2023 $410M +$89.7M +28% Sep 30, 2023 10-Q 2023-11-02
Q2 2023 $393M +$123M +45.7% Jun 30, 2023 10-Q 2023-08-03
Q1 2023 $350M +$87.6M +33.4% Mar 31, 2023 10-Q 2023-05-04
Q4 2022 $336M +$120M +55.7% Dec 31, 2022 10-K 2024-02-05
Q3 2022 $320M +$174M +119% Sep 30, 2022 10-Q 2022-11-03
Q2 2022 $270M +$127M +88.9% Jun 30, 2022 10-Q 2022-08-03
Q1 2022 $262M +$116M +79.8% Mar 31, 2022 10-Q 2022-05-04
Q4 2021 $216M +$48M +28.6% Dec 31, 2021 10-K 2023-02-06
Q3 2021 $146M -$22.9M -13.6% Sep 30, 2021 10-Q 2021-11-04
Q2 2021 $143M -$32.6M -18.6% Jun 30, 2021 10-Q 2021-08-05
Q1 2021 $146M -$15.5M -9.62% Mar 31, 2021 10-Q 2021-05-06
Q4 2020 $168M +$23.4M +16.2% Dec 31, 2020 10-K 2022-02-07
Q3 2020 $169M +$30.9M +22.4% Sep 30, 2020 10-Q 2020-11-05
Q2 2020 $176M +$35.7M +25.5% Jun 30, 2020 10-Q 2020-08-05
Q1 2020 $161M +$16.9M +11.7% Mar 31, 2020 10-Q 2020-05-05
Q4 2019 $145M +$17.3M +13.6% Dec 31, 2019 10-K 2021-02-08
Q3 2019 $138M +$12.7M +10.1% Sep 30, 2019 10-Q 2019-11-05
Q2 2019 $140M +$54.1M +63.2% Jun 30, 2019 10-Q 2019-08-06
Q1 2019 $144M +$65.3M +82.7% Mar 31, 2019 10-Q 2019-05-07
Q4 2018 $127M +$49.5M +63.5% Dec 31, 2018 10-K 2020-02-07
Q3 2018 $125M +$88.6M +242% Sep 30, 2018 10-Q 2018-11-06
Q2 2018 $85.7M +$48.7M +132% Jun 30, 2018 10-Q 2018-08-02
Q1 2018 $79M +$41.9M +113% Mar 31, 2018 10-Q 2018-05-03
Q4 2017 $77.9M +$57.6M +284% Dec 31, 2017 10-K 2019-02-07
Q3 2017 $36.6M +$15.9M +76.9% Sep 30, 2017 10-Q 2017-11-08
Q2 2017 $37M +$30.2M +450% Jun 30, 2017 10-Q 2017-08-03
Q1 2017 $37.1M +$31.3M +540% Mar 31, 2017 10-Q 2017-05-04
Q4 2016 $20.3M +$14.5M +249% Dec 31, 2016 10-K 2018-02-08
Q3 2016 $20.7M +$16.1M +352% Sep 30, 2016 10-Q 2016-11-04
Q2 2016 $6.72M +$2.58M +62.3% Jun 30, 2016 10-Q 2016-08-04
Q1 2016 $5.79M +$1.32M +29.5% Mar 31, 2016 10-Q 2016-05-05
Q4 2015 $5.81M +$2.78M +91.5% Dec 31, 2015 10-K 2017-02-09
Q3 2015 $4.58M +$1.17M +34.2% Sep 30, 2015 10-Q 2015-11-04
Q2 2015 $4.14M -$4.74M -53.4% Jun 30, 2015 10-Q 2015-08-04
Q1 2015 $4.47M -$867K -16.2% Mar 31, 2015 10-Q 2015-05-07
Q4 2014 $3.03M -$2.29M -43% Dec 31, 2014 10-K 2016-02-11
Q3 2014 $3.42M -$993K -22.5% Sep 30, 2014 10-Q 2014-11-04
Q2 2014 $8.88M -$6.33M -41.6% Jun 30, 2014 10-Q 2014-08-05
Q1 2014 $5.34M -$14.7M -73.4% Mar 31, 2014 10-Q 2014-05-08
Q4 2013 $5.33M -$17.8M -76.9% Dec 31, 2013 10-K 2015-02-12
Q3 2013 $4.41M -$13.9M -75.9% Sep 30, 2013 10-Q 2013-11-05
Q2 2013 $15.2M -$4.36M -22.3% Jun 30, 2013 10-Q 2013-08-06
Q1 2013 $20.1M -$315K -1.55% Mar 31, 2013 10-Q 2013-05-03
Q4 2012 $23.1M +$16.9M +270% Dec 31, 2012 10-K 2014-02-13
Q3 2012 $18.3M +$5.3M +40.7% Sep 30, 2012 10-Q 2012-10-24
Q2 2012 $19.6M +$7.28M +59.3% Jun 30, 2012 10-Q 2012-07-25
Q1 2012 $20.4M +$10.2M +99.4% Mar 31, 2012 10-Q 2012-04-26
Q4 2011 $6.24M -$546K -8.04% Dec 31, 2011 10-K 2013-02-15
Q3 2011 $13M +$6.16M +89.8% Sep 30, 2011 10-Q 2011-10-27
Q2 2011 $12.3M +$5.59M +83.5% Jun 30, 2011 10-Q 2011-07-28
Q1 2011 $10.2M Mar 31, 2011 10-Q 2011-05-03
Q4 2010 $6.79M Dec 31, 2010 10-K 2012-02-21
Q3 2010 $6.86M Sep 30, 2010 10-Q 2010-10-28
Q2 2010 $6.7M Jun 30, 2010 10-Q 2010-07-28
* An asterisk sign (*) next to the value indicates that the value is likely invalid.